CLINICAL_TRIALS
trial_result
· 2019-04-12
Clinical Trial Update: Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease [Phase 3]
Summary
Phase 3 trial update on adipose-derived stem cells for complex perianal fistulas in Crohn's disease; trial status terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tigenix S.A.U. | Conditions: Complex Perianal Fistula, Crohn Disease | Phase 3 | Status: TERMINATED